当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析

和邦生物

(603077)

  

流通市值:192.52亿  总市值:192.52亿
流通股本:88.31亿   总股本:88.31亿

和邦生物(603077)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.76亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1876551.47万元,未分配利润957507.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2929399.26万元,负债1052847.79万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,926,520,025.823,921,052,446.511,725,715,319.778,547,476,550.13
营业总成本5,726,755,746.573,858,427,658.11,693,064,580.468,490,183,101.47
其他经营收益
营业利润184,809,095.4455,523,080.5420,884,096.69-61,792,560.91
利润总额170,421,441.5554,981,044.4220,644,011.1-65,683,562.06
净利润76,442,914.4440,239,432.367,535,116.9-70,744,609.93
每股收益
其他综合收益-18,262,832.26-2,688,512.5314,505,248.27-56,289,225.8
综合收益总额58,180,082.1837,550,919.8322,040,365.17-127,033,835.73
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计13,074,335,916.8713,193,620,620.7713,875,476,279.514,003,269,456.63
非流动资产:
非流动资产合计16,219,656,664.3916,029,697,607.1915,969,472,970.5515,646,465,083.25
资产总计29,293,992,581.2629,223,318,227.9629,844,949,250.0529,649,734,539.88
流动负债:
流动负债合计4,264,610,349.874,266,750,910.084,923,063,854.835,374,508,558.61
非流动负债:
非流动负债合计6,263,867,542.146,215,965,766.056,196,525,475.195,268,707,775.63
负债合计10,528,477,892.0110,482,716,676.1311,119,589,330.0210,643,216,334.24
所有者权益(或股东权益):
归属于母公司股东权益合计18,522,695,742.3118,491,495,319.5618,468,988,158.6518,626,392,431.87
股东权益合计18,765,514,689.2518,740,601,551.8318,725,359,920.0319,006,518,205.64
负债和股东权益合计29,293,992,581.2629,223,318,227.9629,844,949,250.0529,649,734,539.88
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计4,794,461,851.953,303,361,952.351,663,561,006.737,679,632,279.6
经营活动现金流出小计4,484,325,324.573,157,892,412.981,718,152,415.437,211,700,892.43
经营活动产生的现金流量净额310,136,527.38145,469,539.37-54,591,408.7467,931,387.17
投资活动产生的现金流量:
投资活动现金流入小计131,673,249.59118,794,561.4830,851,147.3845,571,519.03
投资活动现金流出小计915,384,687.98542,039,294.86368,932,073.751,432,690,999.8
投资活动产生的现金流量净额-783,711,438.39-423,244,733.38-338,080,926.37-1,387,119,480.77
筹资活动产生的现金流量:
筹资活动现金流入小计3,517,758,172.212,757,728,220.332,279,208,350.858,140,310,049.05
筹资活动现金流出小计3,069,863,950.872,476,865,651.661,674,186,984.183,293,099,772.23
筹资活动产生的现金流量净额447,894,221.34280,862,568.67605,021,366.674,847,210,276.82
汇率变动对现金及现金等价物的影响-21,786,823.99-7,911,681.591,784,946.918,709,035.49
现金及现金等价物净增加额-47,467,513.66-4,824,306.93214,133,978.53,946,731,218.71
期末现金及现金等价物余额6,804,095,547.136,846,738,753.867,065,697,039.296,851,563,060.79
补充资料:
现金及现金等价物的净增加额--4,824,306.93-3,946,731,218.71
TOP↑